Krystal Biotech stock price
크리스탈 바이오테크NASDAQ:KRYS · Nasdaq · HealthcareToday's signals · No active technical signal.
Signal details →Krystal Biotech last closed at $322.28 (-0.93%) on 2026-10-02. Listed on Nasdaq. Trailing 12 months PER is 40.9×. Its overall grade ranks 77 of 739 stocks in Healthcare.
About this company
Krystal Biotech last closed at $322.28 (-0.93%) on 2026-10-02. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A · 77/739
Valuation grade F
Related stocks
- RocheCompetitor
희귀 피부질환·유전자치료/바이오 분야에서 간접 경쟁 관계
- Abeona TherapeuticsCompetitor
유전자치료 기반 희귀질환 치료제 개발로 같은 테마 경쟁
- Fibrocell ScienceCompetitor
피부질환 및 유전자·세포치료 영역의 경쟁사로 인식
ETFs holding this stock
Franklin Genomic Advancements ETF · Global X Guru Index ETF · Invesco Russell 2000 Dynamic Multifactor ETF
Details →About Krystal Biotech
- What technical signals does Krystal Biotech (KRYS) have?
- Krystal Biotech current technical signals: no active technical signal.
- Is Krystal Biotech a cup-and-handle pattern?
- No. Krystal Biotech has no valid Cup signal right now.
- What published figures are available for Krystal Biotech?
- Market cap: $9.35B. Trailing 12 months PER: 40.9×. Latest quarter PBR: 7.27×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-03 dataset
Turn what you saw on this name into a strategy
Ask Q about Krystal Biotech, or open the plan table on the main site.
From the names you found, through to a scheduled run
Set the conditions and they run at the scheduled time (live orders are not open yet).